University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis : results from a UK national register

dc.contributor.authorMacfarlane, Gary J
dc.contributor.authorMacDonald, Ross I R
dc.contributor.authorPathan, Ejaz
dc.contributor.authorSiebert, Stefan
dc.contributor.authorGaffney, Karl
dc.contributor.authorChoy, Ernest
dc.contributor.authorPackham, Jon
dc.contributor.authorMartin, Kathryn R
dc.contributor.authorHaywood, Kirstie
dc.contributor.authorSengupta, Raj
dc.contributor.authorAtzeni, Fabiola
dc.contributor.authorJones, Gareth T
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Research Excellence in Musculoskeletal Health: Collaborate. Innovate. Translate.en
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.date.accessioned2018-07-24T11:05:08Z
dc.date.available2018-07-24T11:05:08Z
dc.date.issued2018-11-01
dc.descriptionFunding: This work was supported by Arthritis Research UK (grant 21378) conducted as part of the Fibromyalgia Optimal Management in Axial Spondyloarthritis study.en
dc.description.statusPeer revieweden
dc.format.extent8
dc.format.extent218075
dc.identifier129927525
dc.identifier4c6013da-054d-406c-b02c-196c51951c5b
dc.identifier85055598135
dc.identifier.citationMacfarlane, G J, MacDonald, R I R, Pathan, E, Siebert, S, Gaffney, K, Choy, E, Packham, J, Martin, K R, Haywood, K, Sengupta, R, Atzeni, F & Jones, G T 2018, 'Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis : results from a UK national register', Rheumatology, vol. 57, no. 11, pp. 1982-1990. https://doi.org/10.1093/rheumatology/key206en
dc.identifier.doi10.1093/rheumatology/key206
dc.identifier.issn1462-0324
dc.identifier.otherRIS: urn:031119A450CAB072AAE972126922D4D4
dc.identifier.otherRIS: urn:031119A450CAB072AAE972126922D4D4
dc.identifier.otherORCID: /0000-0003-2322-3314/work/72631710
dc.identifier.otherORCID: /0000-0003-0016-7591/work/83703966
dc.identifier.otherORCID: /0000-0003-4539-7147/work/153002098
dc.identifier.urihttp://hdl.handle.net/2164/10790
dc.language.isoeng
dc.relation.ispartofRheumatologyen
dc.subjectaxial spondyloarthritisen
dc.subjectbiologic therapyen
dc.subjectcohort studyen
dc.subjectco-morbidityen
dc.subjectdisease activityen
dc.subjectdisease registeren
dc.subjectepidemiologyen
dc.subjectfibromyalgiaen
dc.subjectoutcomeen
dc.subjectresponseen
dc.subjectR Medicineen
dc.subjectArthritis Research UK (ARUK)en
dc.subject21378en
dc.subject.lccRen
dc.titleInfluence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis : results from a UK national registeren
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Influence_of_co_morbid_fibromyalgia_on_disease_activity_measures_and_response_to_tumour_necrosis_factor_inhibitors_in_axial_spondyloarthritis_results_from_a_UK_national_register.pdf
Size:
212.96 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description: